
To determine the zzso dose, zzso toxicity zzso and zzso of the zzso inhibitor zzso (formerly zzso in children with zzso or zzso solid zzso 

An intravenous zzso of zzso was administered twice weekly for 2 consecutive weeks at either zzso or zzso zzso followed by a zzso zzso The zzso of zzso were evaluated by measurement of whole blood zzso zzso zzso 

Fifteen patients, 11 zzso were enrolled between November 2001 and February zzso zzso zzso which prevented administration of a complete course (four doses in 2 weeks) of therapy, occurred in two of five zzso children enrolled at the zzso zzso dose zzso There were no other zzso zzso of zzso zzso activity seemed to be dose zzso The average zzso 1 hour after drug administration on day 1 was zzso zzso zzso at the zzso zzso and zzso zzso zzso at the zzso zzso There were no objective zzso zzso 

zzso is well tolerated in children with zzso or zzso solid zzso The recommended phase II dose of zzso for children with solid tumors is zzso zzso administered as an intravenous zzso twice weekly for 2 weeks followed by a zzso zzso 

